1.Weinreb JC,
Barentsz JO,
Choyke PL,
Cornud F,
Haider MA,
Macura KJ,
Margolis D,
Schnall MD,
Shtern F,
Tempany CM et al: PI-RADS Prostate Imaging - Reporting and Data System: 2015,
Version 2.
European urology 2016,
69(1):16-40.
2.Rosenkrantz AB,
Parikh N,
Kierans AS,
Kong MX,
Babb JS,
Taneja SS,
Ream JM: Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go? Academic radiology 2016,
23(6):704-711.
3.Rosenkrantz AB,
Hindman N,
Lim RP,
Das K,
Babb JS,
Mussi TC,
Taneja SS: Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
Journal of magnetic resonance imaging : JMRI 2013,
38(3):694-700.
4.Ueno Y,
Kitajima K,
Sugimura K,
Kawakami F,
Miyake H,
Obara M,
Takahashi S: Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.
Journal of magnetic resonance imaging : JMRI 2013,
38(1):154-160.
5.Wang X,
Qian Y,
Liu B,
Cao L,
Fan Y,
Zhang JJ,
Yu Y: High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.
Clinical radiology 2014,
69(11):1165-1170.
6.Wetter A,
Nensa F,
Lipponer C,
Guberina N,
Olbricht T,
Schenck M,
Schlosser TW,
Gratz M,
Lauenstein TC: High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
Acta radiologica (Stockholm,
Sweden : 1987) 2015,
56(8):1009-1015.
7.Metens T,
Miranda D,
Absil J,
Matos C: What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? European radiology 2012,
22(3):703-709.
8.Agarwal HK,
Mertan FV,
Sankineni S,
Bernardo M,
Senegas J,
Keupp J,
Daar D,
Merino M,
Wood BJ,
Pinto PA et al: Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
Journal of magnetic resonance imaging : JMRI 2016.
9.Ohgiya Y,
Suyama J,
Seino N,
Hashizume T,
Kawahara M,
Sai S,
Saiki M,
Munechika J,
Hirose M,
Gokan T: Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer.
Clinical imaging 2012,
36(5):526-531.
10.Rosenkrantz AB,
Chandarana H,
Hindman N,
Deng FM,
Babb JS,
Taneja SS,
Geppert C: Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.
European radiology 2013,
23(11):3170-3177.
11.Kundel HL,
Polansky M: Measurement of observer agreement.
Radiology 2003,
228(2):303-308.
12.Barentsz JO,
Weinreb JC,
Verma S,
Thoeny HC,
Tempany CM,
Shtern F,
Padhani AR,
Margolis D,
Macura KJ,
Haider MA et al: Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use.
European urology 2016,
69(1):41-49.
13.Rosenkrantz AB,
Ginocchio LA,
Cornfeld D,
Froemming AT,
Gupta RT,
Turkbey B,
Westphalen AC,
Babb JS,
Margolis DJ: Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.
Radiology 2016,
280(3):793-804.
14.Muller BG,
Shih JH,
Sankineni S,
Marko J,
Rais-Bahrami S,
George AK,
de la Rosette JJ,
Merino MJ,
Wood BJ,
Pinto P et al: Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.
Radiology 2015,
277(3):741-750.
15.Renard-Penna R,
Mozer P,
Cornud F,
Barry-Delongchamps N,
Bruguiere E,
Portalez D,
Malavaud B: Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.
Radiology 2015,
275(2):458-468.
16.Schimmoller L,
Quentin M,
Arsov C,
Lanzman RS,
Hiester A,
Rabenalt R,
Antoch G,
Albers P,
Blondin D: Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.
European radiology 2013,
23(11):3185-3190.
17.de Perrot T,
Scheffler M,
Boto J,
Delattre BM,
Combescure C,
Pusztaszeri M,
Tille JC,
Iselin C,
Vallee JP: Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed? Journal of magnetic resonance imaging : JMRI 2016,
44(3):601-609.